4 active not recruiting. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Active not recruiting 4 |
Follow Communication Disorders: new trials by email Literature Review of Communication Disorders trials Research Report on Communication Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of Neflamapimod in Patients With Primary Progressive Aphasia Neflamapimod, Placebo - Nonfluent Variant Primary Progressive Aphasia (nfvPPA) | Phase 2 | Active not recruiting | EIP Pharma Inc | 20 | 2025-10-02 | 2026-07-06 |
| Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin Calcium Levoleucovorin Calcium, Placebo - Autism Spectrum Disorder, Language Disorders | Phase 2 | Active not recruiting | Southwest Autism Research & Resource Center | 80 | 2020-09-22 | 2026-04-27 |
| Leucovorin for the Treatment of Language Impairment in Children With Autism Spectrum Disorder Folinic Acid, Placebo - Autism Spectrum Disorder | Phase 2 | Active not recruiting | Southwest Autism Research & Resource Center | 56 | 2020-08-13 | 2026-04-27 |
| Interventions for Reading Disabilities in NF1 Lovastatin, reading tutoring intervention, Placebo Oral Tablet - Neurofibromatosis Type 1, Learning Disability | Phase 2 | Active not recruiting | Vanderbilt University | 120 | 2016-11-01 | 2026-07-01 |
Language Disorders (3) · Autism Spectrum Disorder (2) · Aphasia (1) · Aphasia, Primary Progressive (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Dyslexia (1) · Frontotemporal Dementia (1) · Learning Disabilities (1) · Mental Disorders (1) · Nervous System Diseases (1) · Neurocognitive Disorders (1) · Neurodegenerative Diseases (1) · Neurofibromatosis 1 (1) · Speech (1)
Neurobehavioral Manifestations (4) · Neurologic Manifestations (4) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Mental Disorders (3) · Nervous System Diseases (3) · Neurodevelopmental Disorders (3) · Child Development Disorders, Pervasive (2) · Behavior (1) · Communication (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Dementia (1) · Frontotemporal Lobar Degeneration (1) · Genetic Diseases, Inborn (1)
Leucovorin (2) · Lovastatin (1)
Southwest Autism Research & Resource Center (2) · EIP Pharma Inc (1) · Vanderbilt University (1)
United States (4) · United Kingdom (1)
Richard E Frye, MD, PhD (2) · Laurie Cutting, PhD (1) · Sheryl L. Rimrodt-Frierson, MD (1)
R01HD088528 (1), R01HD089474 (1)